Evidence map›Paper›PMID 37783722›Full record

ArticleScientific reports2023

Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study).

Diana Barger, Mojgan Hessamfar, Didier Neau, Sophie Farbos, Olivier Leleux, Charles Cazanave, Nicolas Rouanes, Pierre Duffau, Estibaliz Lazaro, Patrick Rispal and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Diana BargerUniv. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France. diana.barger@u-bordeaux.fr.
Mojgan HessamfarUniv. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
Didier NeauCHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France.
Sophie FarbosCH de la Côte Basque, Service de Maladies Infectieuses, 64000, Bayonne, France.
Olivier LeleuxUniv. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.
Charles CazanaveCHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France.
Nicolas RouanesCH de Périgueux, Service de Médecine Polyvalente, 24019, Périgueux, France.
Pierre DuffauCHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.
Estibaliz LazaroCHU de Bordeaux, Service de Médecine Interne, 33604, Pessac, France.
Patrick RispalCH de Agen-Nerac, Service de Médecine Interne, 47923, Agen, France.
François DabisUniv. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
Linda WittkopUniv. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
Fabrice BonnetUniv. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated people living with Human Immunodeficiency Virus' (PLWH) quality of life (QoL) and assessed whether their demographic, disease-related, socioeconomic, or behavioral characteristics were associated with poorer QoL. ANRS CO3 AQUIVIH-NA cohort participants (Nouvelle Aquitaine, France) were recruited to a cross-sectional study (2018-2020) and their QoL assessed (WHOQOL-BREF). We calculated median (Q1, Q3) QoL domain scores and assessed factors associated with poorer median QoL using bivariable and multivariable quartile regression. Of the 965 PLWH included, 98.4% were on antiretroviral therapy, 94.7% were virally-suppressed, 63.5% reported good/very good QoL. Median scores (0-100) were highest for physical (69;Q1, Q3: 56, 81) and environmental (69; 56, 75) QoL and lowest for social (56; 44, 69) and psychological (56; 44, 69) QoL. PLWH with ≥ 3 comorbidities, HIV-related stigma, or income of < 1500€/month had poorer median adjusted physical, psychological, social, and environmental QoL scores compared to reference groups. While more than half of PLWH reported good/very good QoL, we have not achieved good QoL in 90% of PLWH. Multi-morbidity, HIV-related stigma, and social determinants were consistently and independently associated with poorer QoL. Addressing structural factors in addition to those indirectly related to HIV is required to attain good QoL in all PLWH.

Indexed as

HIV InfectionsQuality of LifeCross-Sectional StudiesFranceHIVHumansSurveys and Questionnaires

Identifiers

PMID37783722
PMCPMC10545822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.